S. Rigatos

Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer

G. Stathopoulos, Dimitriοs Mavroudis, Ch. Kouroussis et al. · Annals of Oncology · 2001 · 64 citations

Medicine, Oncology, Pharmacology +15

Front-line paclitaxel–vinorelbine versus paclitaxel–carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial

George P. Stathopoulos, M. Veslemes, Niki Georgatou et al. · Annals of Oncology · 2004 · 61 citations · Full text

Medicine, Oncology, Pharmacology +10

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study

G. Stathopoulos, K. Syrigos, Aristidis Polyzos et al. · Annals of Oncology · 2004 · 58 citations · Full text

Medicine, Oncology, Pharmacology +16

Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer

G. Stathopoulos, S. Rigatos, Meletios Α. Dimopoulos et al. · Annals of Oncology · 2003 · 46 citations · Full text

Medicine, Oncology, Pharmacology +9

Paclitaxel and carboplatin in pretreated advanced gastric cancer: A phase II study

G. Stathopoulos, S. Rigatos, George Fountzilas et al. · Oncology Reports · 2002 · 38 citations

Medicine, Oncology, Pharmacology +14